Merck & Co., Inc.
Time frame: 1 February 2023 - 31 January 2024Article ‘Count’ and ‘Share’ for Merck & Co., Inc. based on listed parameters only.
The articles listed below published by authors from Merck & Co., Inc., organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
Analytical Chemistry |
5 | 2.90 |
Angewandte Chemie International Edition |
7 | 2.54 |
Annals of the Rheumatic Diseases |
1 | 0.08 |
Blood |
3 | 0.43 |
Cancer Cell |
1 | 0.63 |
Chemical Science |
1 | 0.44 |
Circulation |
1 | 0.95 |
Clinical Infectious Diseases |
2 | 0.64 |
International Journal of Epidemiology |
1 | 0.06 |
JAMA: The Journal of the American Medical Association |
1 | 0.50 |
Journal of Clinical Investigation |
2 | 0.14 |
Journal of Clinical Oncology |
6 | 0.24 |
Journal of Hepatology |
1 | 0.69 |
Journal of Infectious Diseases |
1 | 0.63 |
Journal of the American Chemical Society |
11 | 4.11 |
Journal of the American College of Cardiology |
1 | 0.44 |
Nature |
4 | 0.98 |
Nature Chemistry |
3 | 1.20 |
Nature Communications |
11 | 1.84 |
Nature Medicine |
1 | 0.29 |
Nature Methods |
1 | 0.07 |
Organic Letters |
6 | 4.58 |
Pediatrics |
2 | 0.79 |
Proceedings of the National Academy of Sciences of the United States of America |
3 | 1.35 |
Science |
1 | 0.05 |
Science Translational Medicine |
1 | 0.93 |
The BMJ |
1 | 0.25 |
The Journal of Physical Chemistry Letters |
1 | 0.33 |
The Lancet |
5 | 0.88 |
The Lancet Oncology |
8 | 1.04 |
The New England Journal of Medicine |
3 | 0.27 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.